Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use COSOPT safely and effectively. See full prescribing information for COSOPT.COSOPT® (dorzolamide hydrochloride and timolol maleate ophthalmic solution), for topical ophthalmic useInitial U.S. Approval: 1998
Medication labelWhy this: Advisory · dailymed-prescription
COSOPT® is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target IOP determined after multiple measurements over time). The IOP-lowering of COSOPT administered twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol administered twice a day and 2% dorzolamide administered three times a day [see Clinical Studies (14)].
- generic_name
- dorzolamide hydrochloride and timolol maleate
- product_names
- Dorzolamide Hydrochloride and Timolol Maleate
- ndc
- 17478-605, 17478-605-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en